{"id":62911,"date":"2025-02-10T12:45:20","date_gmt":"2025-02-10T17:45:20","guid":{"rendered":"https:\/\/www.businessupturn.com\/usa\/?p=62911"},"modified":"2025-02-10T12:45:20","modified_gmt":"2025-02-10T17:45:20","slug":"stock-market-news-pliant-therapeutics-plunged-by-58-99-while-brand-engagement-network-surged-by-65-83-during-mid-day-trading","status":"publish","type":"post","link":"https:\/\/www.businessupturn.com\/usa\/stock-market-news-pliant-therapeutics-plunged-by-58-99-while-brand-engagement-network-surged-by-65-83-during-mid-day-trading\/62911\/","title":{"rendered":"Stock market news: Pliant Therapeutics plunged by 58.99% while Brand Engagement Network surged by 65.83% during mid day trading"},"content":{"rendered":"<p><span style=\"font-weight: 400\">As of <\/span><b>12:35 PM EST<\/b><span style=\"font-weight: 400\">, several small-cap stocks showed significant movements during the mid day trading session.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u00a0At the first place stood <\/span><b>Pliant Therapeutics, Inc.<\/b><span style=\"font-weight: 400\"> which declined by <\/span><b>58.99%<\/b><span style=\"font-weight: 400\">, while trading at <\/span><b>3.20 USD<\/b><span style=\"font-weight: 400\">, with a market capitalization of <\/span><b>474.05M USD<\/b><span style=\"font-weight: 400\">. The drug developer company\u2019s stock was plunging on Monday after the company on Friday revealed the halt of <\/span><span style=\"font-weight: 400\">\u00a0enrollment and dosing in mid-stage trial testing its experimental lead drug, bexotegrast, to treat a type of lung disease called idiopathic pulmonary fibrosis.\u00a0<\/span><\/p>\n<p><b>Global Star Acquisition, Inc.<\/b><span style=\"font-weight: 400\"> dropped <\/span><b>10.68%<\/b><span style=\"font-weight: 400\">, with its stock priced at <\/span><b>9.20 USD<\/b><span style=\"font-weight: 400\">, and a market cap of <\/span><b>30.31M USD<\/b><span style=\"font-weight: 400\">. However, <\/span><b>Brand Engagement Network Inc.<\/b><span style=\"font-weight: 400\"> surged <\/span><b>65.83%<\/b><span style=\"font-weight: 400\">, trading at <\/span><b>0.6799 USD<\/b><span style=\"font-weight: 400\">, with a market capitalization of <\/span><b>25.79M USD<\/b><span style=\"font-weight: 400\">.<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u00a0<\/span><b>Cyngn Inc.<\/b><span style=\"font-weight: 400\"> saw a sharp rise of <\/span><b>138.87%<\/b><span style=\"font-weight: 400\">, with its stock price at <\/span><b>0.1438 USD<\/b><span style=\"font-weight: 400\">, and a market cap of <\/span><b>1.65M USD<\/b><span style=\"font-weight: 400\">. On the other hand, <\/span><b>Ocean Biomedical, Inc.<\/b><span style=\"font-weight: 400\"> gained <\/span><b>11.96%<\/b><span style=\"font-weight: 400\">, with shares priced at <\/span><b>0.1488 USD<\/b><span style=\"font-weight: 400\">, and a market capitalization of <\/span><b>5.19M USD<\/b><span style=\"font-weight: 400\">. The stock was up on Monday <\/span><span style=\"font-weight: 400\">after the company announced breakthrough findings in EGFR-Mutant lung cancer while it also plans for FDA alignment for the next stage.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Lastly in the consumer services sector\u00a0 <\/span><b>Bally\u2019s Corporation<\/b><span style=\"font-weight: 400\"> fell <\/span><b>20.31%<\/b><span style=\"font-weight: 400\">, trading at <\/span><b>14.54 USD<\/b><span style=\"font-weight: 400\">, with a market cap of <\/span><b>591.09M USD<\/b><span style=\"font-weight: 400\">.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Disclaimer: This article is for informational purposes only and does not constitute any financial advice.\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00a0At the first place stood Pliant Therapeutics, Inc. which declined by 58.99%, while trading at 3.20 USD, with a market capitalization of 474.05M USD.<\/p>\n","protected":false},"author":433,"featured_media":52613,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[73],"tags":[24734,24733,24663,24649,24590,24738],"class_list":["post-62911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-us-markets","tag-ballys-corporation","tag-brand-engagement-network","tag-cyngn","tag-global-star-acquisition","tag-ocean-biomedical","tag-pliant-therapeutics"],"reading_time":"2 min read","_links":{"self":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/62911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/users\/433"}],"replies":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/comments?post=62911"}],"version-history":[{"count":0,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/posts\/62911\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media\/52613"}],"wp:attachment":[{"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/media?parent=62911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/categories?post=62911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.businessupturn.com\/usa\/wp-json\/wp\/v2\/tags?post=62911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}